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The endocytic compartment of polarized cells is orga-
nized in basolateral and apical endosomes plus those
endocytic structures specialized in recycling and trans-
cytosis, which are still poorly characterized. The com-
plexity of the various populations of endosomes has
been demonstrated by the exquisite repertoire of endog-
enous proteins. In this study we examined the distribu-
tion of cellubrevin in the endocytic compartment of
hepatocytes, since its intracellular location and func-
tion in polarized cells are largely unknown. Highly pu-
rified rat liver endosomes were isolated from estradiol-
treated rats, and the early/sorting endosomal fraction
was further subfractionated in a multistep sucrose den-
sity gradient, and studied. Analysis of dissected endoso-
mal fractions showed that cellubrevin was located in
early/sorting endosomes, with Rab4, annexins II and VI,
and transferrin receptor, but in a specific subpopulation
of these early endosomes with the same density range as
pIgA and Raf-1. Interestingly, only in those isolated en-
dosomal fractions, endosomes enriched in transcytotic
structures (of livers loaded with IgA), the polymeric im-
munoglobulin receptor specifically co-immunoprecipi-
tated with cellubrevin. In addition, confocal and im-
muno-electron microscopy identification of cellubrevin
in tubular structures underneath the sinusoidal plasma
membrane together with the re-organization of cel-
lubrevin, in the endocytic compartment, after the IgA
loading, strongly suggest the involvement of cellubrevin
in the transcytosis of pIgA.
Receptor-mediated endocytosis is a process in which eukary-
otic cells selectively internalize macromolecules and a large
variety of extracellular solutes. In general, the main features of
this pathway are relatively well understood and involve the
internalization of receptor/ligand complexes via clathrin-coated
pits and vesicles that rapidly lose their coat to fuse with the
early/sorting endocytic compartment. Whereas receptors are
sorted and diverted into a complex tubular network of mem-
branes, and recycle back to the plasma membrane, ligands are
targeted into the late endosomes and eventually to the lysoso-
mal compartment for degradation. Although this is still consid-
ered the main route, different ports of entry have now been
described, for example by non-clathrin-coated pits and/or by
caveolae (1). Indeed, the endocytic destination for these differ-
ent ports of entry could also differ, as could the connections
between intracellular pathways along the endocytic stations,
which are multiple and complex. Thus, whether endosomes
undergo maturation (2) or whether endocytic carrier vesicles
are transported through pre-existing (3) early and late endo-
cytic compartments is still a matter of controversy. Besides, the
possibility that, in some cells, early and late endosomes are
part of an extensive tubular endocytic network has recently
been shown (4).
In polarized epithelial cells, surface polarity is generated and
maintained by the membrane trafficking along the exocytic and
endocytic pathways. For this reason, it is crucial to understand
the molecular mechanism(s) as well as the endosomal constit-
uents which contribute to these processes.
Cellubrevin is a ubiquitous intracellular integral membrane
protein involved in the constitutive recycling pathway (5, 6). It
belongs to the v-SNARE1 family (synaptobrevin/VAMP-related
protein) and, like synaptobrevin II (VAMP-2), it is proteolysed
by tetanus toxin light chain. Recently, the localization of dif-
ferent SNAREs in MDCK cells and in CaCo-2 cells has been
defined (7, 8). Galli et al. (8) showed that cellubrevin was
present in both the lateral and the apical membrane domains of
CaCo-2 cells. However, its precise function in polarized cells
remains unknown.
In the hepatocyte, it is generally assumed that there is a
default biosynthetic transport of membrane proteins to the
basal surface (sinusoidal plasma membrane). From there on
and through the endocytic compartment, there is a specialized
transcellular transport to the bile canalicular plasma mem-
brane (apical domain), where transcytosis is accomplished (e.g.
transcytosis of pIgA). Although this is assumed to be the main
route, evidence for direct targeting into the apical (bile cana-
licular) plasma membrane has been reported (9–11). Less
known is the route for the incorporation of membrane proteins
into the lateral plasma membrane, e.g. connexins, which as-
semble in a gap junction (12), or desmosomal glycoproteins.
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Two different intracellular regions actively involved in the
sorting and processing of endocytosed ligands and receptors
have been depicted in the hepatic cell: 1) the subapical endo-
cytic compartment (13, 14) involved in the deep recycling of
receptors, such as the ASGP-R (15), in the late stages of trans-
cytosis of pIgA (16) and defined by its enrichment of annexin VI
(17). Topologically, is located around the bile canaliculus and is
close to the Golgi-lysosomal region of the cell. 2) Less charac-
terized are the basolateral early/sorting endosomes at the sub-
sinusoidal region of hepatocyte, presumably involved in the
rapid (constitutive) recycling of receptors back to the sinusoidal
plasma membrane, in the early sorting of molecules for tran-
scytosis and, as shown recently, in the activation of signal
transduction (18).
In this study we demonstrated that cellubrevin is specifically
located in these early/sorting subsinusoidal endocytic struc-
tures. It shows an almost restricted location underneath the
sinusoidal plasma membrane of hepatocytes, but after exoge-
nous pIgA uptake it “moves” to the subapical domain, along the
transcytotic pathway. Since no change in the cellubrevin-stain-
ing pattern was observed, in livers loaded with ligands that
enter by receptor-mediated endocytosis (e.g. LDL) or by fluid
phase markers (e.g dextran-FITC) and that follow the degra-
dation pathway, we conclude that cellubrevin may be involved
in transcytosis of IgA through the endocytic compartment.
EXPERIMENTAL PROCEDURES
Animals and Reagents—Male Harlan Sprague-Dawley rats weighing
200–250 g were maintained under a controlled lighting schedule with
12-h dark period. All animals received humane care in compliance with
institutional guidelines. Food and water were available ad libitum.
pIgA was from Nordic Immunological Laboratories (Tilburg, The
Netherlands); dextran-FITC (Mr 70,000) was from Molecular Probes
(Leiden, The Netherlands). Human LDL (1.025 , d , 1.050 g/ml) was
isolated from normolipidemic adult humans (19).
Antibodies—The rabbit polyclonal affinity-purified antibody to mem-
brane-bound annexin VI (17) was provided by Dr. S. Jäckle (University
of Hamburg), and the rabbit affinity-purified anti-cellubrevin (20) was
prepared in our laboratory. Mouse anti-transferrin receptor and anti-
pIgR (SC-166) monoclonal antibodies were kindly provided by Dr. K. E.
Mostov (University of California, San Francisco, CA). Mouse mono-
clonal antibodies to anti-annexin II (A14020) and anti-Raf-1 (R-19120)
were from Transduction Laboratories (Lexington, KY). Rabbit poly-
clonal affinity-purified anti-Rab4 (sc-312) was from Santa Cruz Bio-
technology (Santa Cruz, CA). A rabbit anti-human apoB100 polyclonal
antibody was kindly donated by Dr. Ulrike Beisiegel (University of
Hamburg). Finally, a monoclonal anti-human IgA (a-chain-specific)
(clone GA-112) was from Sigma (Madrid, Spain). Fluorescently conju-
gated (FITC and Cy 3) antibodies were from Jackson ImmunoResearch
(West Grove, PA).
Isolation of Endosomes and Plasma Membrane from Rat Liver—
After 3 days of 17-a-ethinyl estradiol treatment to induce the expres-
sion of the low density lipoprotein receptors (21), rats were anesthetized
with isofluorane, and human LDL (5 mg of protein) was injected into
the femoral vein. 20 min later, livers were removed and homogenized in
0.25 M sucrose with protease inhibitors. The method used for the isola-
tion of the endosomal fractions from rat liver is described elsewhere (22,
23). Three distinct endosomal fractions were obtained after centrifuga-
tion of a crude endosome fraction in a sucrose gradient: MVB at 8.24%/
19.3%, CURL at 19.3%/28.81%, and RRC at 28.81%/36.37% (w/v) inter-
faces. Each fraction was collected, and ice-cold water was added to
render the fractions isotonic. The isotonic fractions were pelleted, re-
suspended in 0.9% NaCl, and stored at 280 °C.
In some experiments, the interface corresponding to CURL or to RRC
were mixed with heavy sucrose (2.5 M) and loaded at the bottom of a
discontinuous sucrose gradient with 19%, 21%, 23%, 25%, 27%, and
29% sucrose (w/v) for CURL or 29%, 31%, 33%, 35%, 37%, and 39% for
RRC, and the tubes were centrifuged at 28,000 rpm for 2 h 50 min, in
a Beckman SW28 rotor. Following centrifugation, the interfaces were
unloaded, pelleted, resuspended in 0.9% NaCl, and stored at 280 °C.
The same procedure was also performed in those experiments where
IgA was injected into the portal vein.
A plasma membrane fraction derived from the lateral and canalicu-
lar domains of the hepatocyte was isolated essentially according to the
method described by Neville (24).
Gel Electrophoresis, Immunoblots, Immunoprecipitation, and Densi-
tometry—SDS-PAGE of proteins was performed in 10% or 12% poly-
acrylamide, as described by Laemmli (25). For Western blotting,
polypeptides (3–5 mg of protein/channel) were transferred electro-
phoretically at 60 V for 60–90 min at 4 °C (depending on the proteins to
be identified) to Immobilon-P transfer membranes (Millipore), and an-
tigens were identified using specific antibodies diluted in Tris-buffered
saline containing 0.5% powdered skimmed milk, and finally the reac-
tion product was detected using the ECL system (Amersham Pharma-
cia Biotech). Image analysis of Western blots and band quantification
were performed with a Bio-Image system (Millipore).
For cellubrevin immunoprecipitation, 50 mg of protein of the endoso-
mal fractions RRC and CURL, from control and from IgA-injected rats,
were solubilized with 1% Triton X-100, 10 mM Hepes, pH 7.4, 140 mM
KCl, 10 mM EDTA on ice, containing the following proteinase inhibitors:
50 mM NaF, 0.1 mM sodium vanadate, 1 mM phenylmethylsulfonyl
fluoride, and 10 mg/ml leupeptin. After removal of the insoluble mate-
rial in a microcentrifuge, the soluble fractions were incubated with
rabbit anti-cellubrevin antibody or with normal rabbit serum (control)
overnight at 4 °C. Protein immunocomplexes were then incubated with
Protein A-Sepharose (Pierce) for 1 h at 4 °C, collected by centrifugation,
and washed three times with the same buffer used for solubilization
except that 0.1% Triton X-100 was used.
For the pIgR immunoprecipitation, the mouse monoclonal anti-pIgR
antibody (SC-166) was used according the procedure described by Luton
et al. (26); briefly, liver endosomal fractions (50 mg of protein), with or
without IgA, were solubilized in a freshly buffer of 1% Nonidet P-40, 125
mM NaCl, 20 mM HEPES (pH 7.4), 10 mM NaF, 2 mM sodium vanadate,
and protease inhibitor mixture. After washing, immunoprecipitated
proteins were resolved by SDS-PAGE, and the presence of coimmuno-
precipitated pIgR or cellubrevin analyzed by Western blotting. A non-
related monoclonal antibody was used as control.
The protein content of the samples was measured by the method of
Bradford (27) using bovine serum albumin as standard.
Immunofluorescence Studies in Liver and in Isolated Primary Cul-
tured Hepatocytes: Uptake of pIgA, LDL, Transferrin-FITC, and Dex-
tran-FITC—pIgA (100 mg), LDL (5 mg), or dextran-FITC (5 mg) (Mr
70,000) or 0.9% NaCl for control animals, were injected into the portal
vein (except for LDL, which was injected into the femoral vein) of
Harlan Sprague-Dawley (200–250 g) rats anesthetized with isoflu-
orane, and 2.5 or 20 min later livers were perfused with 2% paraform-
aldehyde-PBS (50 ml). Small pieces of liver were post-fixed for 2 h in the
same fixative, then washed in PBS and cryoprotected by sucrose em-
bedding, and finally frozen on dry ice. Cryostat sections (6–8 mm) were
obtained, air-dried, and hydrated in PBS before immunostaining (15).
Confocal microscopy (Leica TCS NT) was used to collect the images,
equipped with a 633 Leitz Plan-Apo objective (numeric aperture 1.4).
Images represent approximately 1.0-mm optical sections. Adobe Photo-
shop software (Adobe Systems, San Jose, CA) was used for image
processing.
Finally, in some experiments, hepatocytes in primary culture were
prepared from Harlan Sprague-Dawley rats by liver perfusion using
collagenase type IV (28) (30 mg/ml Hanks’ medium) (Sigma). Isolated
hepatocytes were allowed to attach overnight at 37 °C in a CO2 incu-
bator before fixation.
In hepatocytes, transferrin-FITC (20 mg/ml) in 0.5% BSA/Hepes-
buffered serum-free medium was internalized over 60 min. After
washes, cells were fixed in PLP (4% paraformaldehyde in 40 mM sodium
phosphate, 75 mM lysine buffer (pH 7.4) containing 9.1 mM sodium
periodate) fixative and permeabilized with 0.1% saponin in 0.5% BSA/
PBS, 20 mM glycine for 10 min. Cells were subsequently processed for
indirect immunofluorescence with anti-cellubrevin antibody and a goat
anti-rabbit IgG F(ab)92-conjugated-Cy 3 secondary antibody. Finally,
cells on coverslips were mounted on glass slides with Mowiol and
examined under a confocal microscope.
Immunoelectron Microscopy—For electron microscopy, rat livers
were perfused in situ with 50 ml of PBS containing 2 mM CaCl2 and 2
mM MgCl2 and then with 100 ml of 2% paraformaldehyde, 0.1% glut-
araldehyde in 0.1 M phosphate buffer, pH 7.2, containing 3% polyvi-
nylpyrrolidone (15). Liver pieces were placed in cold fixative, further
dissected, and left in fixative overnight at 4 °C. The tissue was then
washed in PBS and incubated in 0.5 M NH4Cl in PBS for 60 min. at 4 °C.
After washing in PBS, the tissue was dehydrated with increasing con-
centrations of ethanol in distilled water (30 min/change) on ice up to
75% ethanol, transferred to 95% ethanol and then to absolute ethanol,
both changes at 220 °C for 2 h each. Tissue samples were then infil-
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trated with Lowicryl K4M:ethanol (1:2 and then 2:1 at 220 °C for 1 h
each) and then with daily changes of undiluted Lowicryl for 1 week at
220 °C. For polymerization, each piece of liver was transferred to a
gelatin capsule containing Lowicryl and left under UV (360 nm) over-
night at 235 °C and then for additional 48 h at room temperature.
Ultrathin sections were cut using a Reichert Ultracut E microtome and
collected on Formvar-coated gold grids. For cellubrevin localization,
grids were incubated for 1 h at room temperature with primary anti-
bodies (1:10) in PBS containing 1% BSA. After washing, the grids were
incubated for 1 h at room temperature with protein A conjugated to
colloidal gold particles in PBS containing 1% BSA, 0.075% Triton X-100,
0.075% Tween 20. After several washes, sections were stained with
saturated ethanolic uranyl acetate, counterstained with lead citrate,
and examined in a Hitachi HT-600 electron microscope. As control for
immunostaining, sections were incubated with the second antibodies
(protein A-gold) only; the labeling was specific as no signal was obtained
(data not shown).
RESULTS
Cellubrevin is a ubiquitous integral membrane protein,
abundantly expressed in the liver but with a completely un-
known intracellular location and function. By using an affinity-
purified polyclonal antibody to cellubrevin (developed and
characterized in our laboratory (Ref. 20)), we studied the intra-
cellular distribution of this v-SNARE protein in rat liver and in
isolated endosomes.
Highly purified endosomes from estradiol-treated rats were
used to find out the distribution of cellubrevin in the hepatic
endocytic compartment. The high level of purity of the three
endosomal fractions, isolated from rat liver by the method
developed by Havel and co-workers, is well documented (22, 23,
29–33). Recently, we have also carried out a detailed compre-
hensive biochemical characterization of these endosomal frac-
tions (18, 34–36).
Cellubrevin Distribution in Isolated Rat Liver Endosomes—
Fig. 1 shows the distribution of cellubrevin by Western blotting
in the endosome and plasma membrane fractions isolated from
rat liver. Cellubrevin was specifically enriched in two of the
endosomal fractions (CURL, 45% and RRC, 40%). The late
endosomal fraction (MVB) contained only 15% of the total
cellubrevin. Cellubrevin was also detected in a Golgi-isolated
fraction (10 -20%, compared with the amount of TGN38; data
not shown) but was not detected in a plasma membrane frac-
tion isolated from rat liver (this fraction was mainly from the
canalicular/lateral plasma membrane domains). CURL has
been characterized as the early/sorting compartment, whereas
the RRC is a more complex fraction that includes recycling (22,
23) and transcytotic endosomes (37) but also contains caveolin
(38). Electron microscopy of isolated fractions showed the dif-
ferential morphology between isolated endosomes; whereas
MVB is always a very homogeneous fraction, CURL and RRC
showed a certain degree of heterogeneity, most probably re-
flecting the presence of various subpopulations of “early” and
“recycling” endosomes.
In order to dissect and further characterize the early endo-
cytic structures, we attempted to separate them in an addi-
tional subfractionation step. Isolated CURLs were loaded in an
additional continuous sucrose density gradient, and fractions
were separated by flotation at 28,000 rpm for 2 h and 50 min
(see “Experimental Procedures” for details). Samples unloaded
from different densities of the gradient were analyzed by West-
ern blotting. The amount and the distribution of annexin VI,
transferrin receptor, Rab4, and annexin II were very similar
along the 19–29% (w/v) sucrose density gradient (Fig. 2). In-
terestingly, cellubrevin, pIgA, and Raf-1 showed a more re-
stricted distribution, with a peak in the middle of the sucrose
gradient (25% sucrose).
Intracellular Location of Cellubrevin in Rat Liver: Confocal
and Electron Microscopy—The distribution of cellubrevin was
studied and compared with annexin VI as an endosomal
marker for the apical endosomes (17). Examination of frozen
sections of rat liver treated with the affinity-purified anti-
annexin VI antibody showed that fluorescence was concen-
trated predominantly in the canalicular (apical) region of hepa-
tocytes (Fig. 3b). The staining with anti-cellubrevin affinity-
purified antibody shows the labeling in the subsinusoidal
(basal) region of hepatocytes (Fig. 3a) (double labeling was not
attempted because both antibodies were polyclonal). Controls
using antibodies to antigens located at the plasma membrane
of endothelial cells (RECA-1) clearly showed labeling with anti-
cellubrevin in the hepatocyte (data not shown).
In some experiments, the intracellular location of cellubrevin
was also examined in primary cultured hepatocytes. Cellubre-
vin showed a punctate, vesicular, staining underneath the
plasma membrane around single cells or, in couplets, it was
also observed in the pericanalicular (Golgi-lysosomal) region
(Fig. 3c). In these experiments, transferrin-FITC was internal-
ized for 60 min, then cells were fixed and immunolabeled with
anti-cellubrevin antibody; Fig. 3d shows that cellubrevin did
not co-localize with the recycling transferrin compartment, in
the perinuclear region of hepatocytes.
Finally, to examine in more detail the type of structures
labeled by the anti-cellubrevin antibody, immuno-electron mi-
croscopy was performed on Lowicryl sections. Fig. 4 shows
representative areas in which intracellular subsinusoidal
structures were labeled with anti-cellubrevin antibody (protein
A and 10 nm gold used as a secondary antibody). Tubules, but
also vesicles and tubulovesicular endocytic structures close to
the sinusoidal plasma membrane, can be observed with scat-
tered gold labeling on the cytoplasmic face. A few small vesicles
were also labeled with anti-cellubrevin in the pericanalicular
region of the hepatocyte (subapical endocytic compartment),
where most of the endocytic structures were larger and with
vesiculotubular morphology (positive for annexin VI; see
FIG. 1. Distribution of cellubrevin in rat liver endosomes. Rep-
resentative Western blot of cellubrevin distribution in isolated rat liver
endosomes and plasma membrane (4 mg/lane). CURL (45 6 5%) and
RRC (40 6 8%) are the endosomal fractions enriched in cellubrevin (n 5
7). PM, hepatocyte plasma membrane fraction.
FIG. 2. Biochemical dissection of CURL. Isolated early sorting
endosomes (CURL) were loaded at the bottom of a multistep sucrose
gradient (from 17% to 31% w/v) and centrifuged for 2 h and 50 min at
20,800 rpm, in a SW28 rotor. Samples from this gradient (2 ml) were
pelleted, resuspended in 0.9% NaCl, TCA-precipitated, electrophoresed
(4 mg/lane), and transferred to Immobilon-P membranes. Western blot-
ting was used to analyze the distribution of proteins along the gradient.
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Ortega et al. (Ref. 17)).
Reorganization of Cellubrevin-containing Endocytic Com-
partment upon IgA Internalization—To assess the possible in-
volvement of cellubrevin containing endocytic structures in the
transcytotic route of the hepatic cell, exogenous pIgA (100 mg)
was injected into the portal vein and 2.5 and 20 min later livers
were removed and immunocytochemical studies were per-
formed (control livers were injected with 0.9% NaCl). Human
IgA was efficiently taken up by the liver of normal and estra-
diol-treated rats; 15 min after intravenous injection, approxi-
mately 50% was recovered in the liver (37).
Fig. 5 shows the immunocytochemical localization of cel-
lubrevin in control (0.9% NaCl) and in IgA-injected rats. Rat
liver frozen sections were double labeled with anti-cellubrevin
antibodies, followed by the secondary fluorescently labeled goat
anti-rabbit IgG-FITC and a mouse anti-human IgA followed by
a rabbit anti-mouse IgG-Cy 3. Cellubrevin (optical section from
confocal microscopy) was mainly concentrated underneath the
sinusoidal plasma membrane domain of hepatocytes (Fig. 5a).
The labeling with anti-mouse human IgA showed little cross-
reactivity with the endogenous rat IgA (Fig. 5b).
When a pulse of exogenous pIgA (100 mg) was given and
livers analyzed 2.5 and 20 min later, it can be observed that,
although the subsinusoidal cellubrevin staining remained (ar-
rowheads), a subapical cellubrevin labeling emerged in some
hepatocytes after 20 min, which co-localized with IgA (Fig. 5g,
arrows; see also overlay panels c, f and i). After 2.5 or 20 min,
the exogenous IgA was detected inside the hepatocytes and at
the sinusoidal plasma membrane (Fig. 5, e and h) (in agree-
ment with studies of Hoppe et al. (39). Insets (in a, g, h, and i)
show details of the re-organization of cellubrevin-containing
structures in the hepatic endocytic compartments after IgA
injection.
However, in livers in which dextran-FITC, as a fluid-phase
marker (Fig. 6, a and b), or LDL, a ligand that follows the
degradation pathway (c, d), was injected (for 20 min), the
pattern of cellubrevin labeling in the hepatic cell did not
change, remaining associated with the subsinusoidal region of
hepatocytes. An anti-apoB100 specific antibody was used for
the detection of LDL in the intact liver (double labeling was not
possible because both antibodies were rabbit polyclonals).
The observation of the immunocytochemical data (Fig. 5)
suggested a possible involvement of cellubrevin-containing
structures in the transport of IgA from the subsinusoidal re-
gion of the hepatocyte to the pericanalicular area onward to
transcytosis.
Two experimental approaches provided significant data sup-
porting this idea. First of all, we studied the subcellular distri-
bution of cellubrevin in endosomal fractions from control
(NaCl) and from livers previously loaded with pIgA (20 min,
100 mg). Endosomal fractions were prepared and further frac-
tionated, by flotation, in a multistep sucrose gradients as de-
scribed under “Experimental Procedures.” Unloaded samples
FIG. 3. Immunocytochemical distribution of cellubrevin in rat
liver and in isolated hepatocytes. Frozen sections from rat liver
(6–8 mm) were used to study the localization of cellubrevin (a) and
compared with annexin VI (b). Sections were incubated with respective
primary antibodies, followed by anti-rabbit FITC-conjugated secondary
antibodies. Cellubrevin labeling is concentrated in the subsinusoidal
region of hepatocytes (arrowheads). On the other hand, annexin VI is
mostly in the pericanalicular (subapical) regions of hepatic cells (ar-
rows). Isolated primary cultured hepatocytes (c and d) were also used to
examine the intracellular location of cellubrevin (c) and to compare with
the location of the recycling endocytic compartment (d). Transferrin-
FITC was internalized for 60 min, and cells were fixed and immunola-
beled with anti-cellubrevin antibody. In couplets of hepatocytes, cel-
lubrevin showed a punctate pattern underneath the plasma membrane
but also in the pericanalicular region (Golgi-lysosomal region). After 60
min (pulse) of transferrin-FITC internalization (d), pairs of arrows in c
and d point the little co-localization of transferrin-FITC and cellubrevin
in the perinuclear recycling endosomes. Bar is 10 mm.
FIG. 4. Localization of cellubrevin in rat liver: immunoelec-
tron microscopy. Ultrathin Lowicryl sections labeled with the affinity
purified anti-cellubrevin antibody. Micrographs show representative
fields of the sinusoidal (a–e) or the apical ( f ) regions of hepatocytes.
Labeling (10 nm gold) is concentrated mainly in tubules, vesicles, or
tubulovesicular structures (arrowheads) close to the sinusoidal plasma
membrane. In the apical, pericanalicular region, only few small vesicles
were labeled (arrowheads in f ). bc, bile canaliculus; sin, sinusoidal
domain. Bar is 100 nm.
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were analyzed by Western blotting to find out the distribution
of cellubrevin. Fig. 7a shows the displacement of the cellubre-
vin containing endosomal fractions, toward the heavy density
range, in both CURL and RRC, after the load with IgA. As a
control, the same gradients were analyzed for the distribution
of annexin VI; in this case, no change in the patterns of annexin
VI distribution along the densities studied in control or in IgA
containing fractions could be observed (Fig. 7b). A further
control included the biochemical analysis of the distribution of
endosomal proteins in endocytic fractions with or without the
administration of LDL; the results showed no changes in their
qualitative or quantitative distribution (data not shown). The
distribution of IgA (as control) in the density gradient, after
IgA injection, becomes more homogeneous, compared with the
control profile (especially in the CURL density range) (Fig. 7c).
Second, CURL and RRC fractions, before subfractionation,
isolated from control and from livers loaded with pIgA (for 20
min) were used for coimmunoprecipitation experiments, with
anti-cellubrevin or anti-pIgR (mouse monoclonal SC-166,
which recognizes the cytoplasmic domain of the pIgR), to test
whether cellubrevin was associated with pIgR in the endocytic
fractions. Interestingly, coimmunoprecipitation takes place in
FIG. 5. Immunocytochemical distribution of cellubrevin and pIgA in rat liver frozen sections. Human pIgA (100 mg) was intravenously
injected in rats, and after 2.5 or 20 min, livers were fixed, removed, and prepared for double immunolabeling with anti-cellubrevin (a, d, g;
FITC-labeled) and anti-IgA antibodies (b, e, h; Cy 3-labeled). Cryostat sections (6 mm) were used to study the cellubrevin and IgA distribution in
the hepatic tissue. Representative optical sections (1 mm) of fields imaged with a confocal microscopy of control (0.9% NaCl) section where the
cellubrevin staining is concentrated in the subsinusoidal region of hepatocytes (a); the same field showed that the human anti-mouse IgA did not
recognize the endogenous rat IgA (b). After 2.5 min of pIgA injection, there was no significant change in the structures containing cellubrevin (d).
IgA was detected inside but predominantly in the sinusoidal plasma membrane of hepatocytes (e). However, after 20 min of IgA some cellubrevin
labeling can be observed in the pericanalicular regions (g) (arrows) although the labeling at the sinusoidal spaces remains (arrowheads).
Co-localization of the two antibodies indicates that at this time point (20 min) some of cellubrevin endocytic structures contained IgA (h). Panels
c, f, and i show the merged images. Insets show detailed magnified regions for comparison. n, nucleus. Bar is 10 mm.
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RRC fractions isolated from the livers loaded with IgA (Fig. 7,
d and e).
From these data, we conclude: 1) overloading the transcytotic
pathway (with IgA) perturbs the density of those structures in
CURL and RRC containing cellubrevin, and 2) cellubrevin and
pIgR reciprocally coimmunoprecipitated the other one, only in
the RRC fractions isolated from rats loaded with IgA, suggest-
ing that these two proteins must be in the same transcytotic
vesicles.
DISCUSSION
According to the SNARE hypothesis, soluble NSF attach-
ment protein (SNAP) receptors on a vesicle membrane (v-
SNARE) bind to SNAP receptor proteins on the target mem-
brane (t-SNARE) in the process of vesicle docking. Fusion of the
docked vesicle with the target membrane also involves the
binding of the soluble proteins a-SNAP and NSF to this
SNARE complex, driven by the ATPase activity of NSF. Thus,
the v- and t-SNARE families would determine the specificity of
vesicular transport. However, a growing body of evidence
shows that specificity of the fusion event is a very complex and
synchronized process, which also requires other cofactors such
as the Rab proteins (Rab5), docking proteins (early-endosomal
autoantigen-1, Rabaptin-5), protector proteins (n-Sec1), or “sta-
bilizing” proteins (LMA-1) (for a recent review, see Ref. 40).
Cellubrevin, which belongs to the v-SNARE family, has been
implicated in membrane trafficking and in constitutive and
regulated secretion. However, although cellubrevin was de-
tected in the liver (5), no attempts to elucidate its subcellular
distribution or its involvement in the secretory or endocytic
pathways in the hepatocyte have been reported.
Hepatocytes display two independent constitutive secretory
pathways: one to the blood, through the basolateral plasma
membrane (e.g. lipoproteins, albumin, or fibronectin) and a
second into the bile through the apical, canalicular, plasma
membrane (e.g. bile acids). Transcytosis, a major intracellular
transport pathway unique to polarized epithelial cells, is an
additional constitutive secretory route. Very few proteins have
been identified as being involved in its regulation in the hep-
atocyte (41–43) or in MDCK cells (44–48). Interestingly, cal-
modulin and several calmodulin-binding proteins in the corti-
cal cytoskeleton may be crucial for the regulation of the first
and last steps of transcytosis (for example: myosin I, gelsolin,
a-actinin, spectrin, or adducin) (33, 35).
While cellubrevin has been related to early recycling events
in non-polarized cells (6, 49), its function in polarized epithelial
cells is unknown. Several studies have shown the distribution
of different SNAREs in polarized cells (7, 8, 50, 51); cellubrevin
was detected in intracellular organelles localized both in the
lateral and in the apical domains of CaCo-2 cell line (8).
Recently, a study in rat liver showed the distribution of
different endogenous syntaxins (t-SNARES) in the hepatocyte
plasma membrane. Interestingly, syntaxin 2 and 3 were shown
to be enriched in the apical plasma membrane, whereas syn-
taxin 4 was mainly expressed in the sinusoidal plasma mem-
brane (52). A significant amount of syntaxin 3 was also de-
tected in subcellular fractions containing transport vesicles.
Syntaxins 2 and 3 were found enriched in the RRC and in
CURL endosomal fractions from rat liver (53).
Whether syntaxins confer specificity to the targeting event
remains to be determined, but the predominant location of
those syntaxins in the canalicular plasma membrane might be
a signal for a major docking of the corresponding v-SNARE. If
cellubrevin were involved in the apical transcytosis in the
hepatocyte, then a so far unidentified t-SNARE would be bind-
ing partner. Since syntaxins 2 and 3 are located in the bile
canalicular plasma membrane, they are good candidates for
cellubrevin interaction. Interestingly, in CaCo-2 cells, it has
been demonstrated that syntaxin 3 and SNAP23 form apical
SNARE complexes, which provides the first evidence for the
involvement of cellubrevin and a new v-SNARE, TI-VAMP
(tetanus neurotoxin-insensitive VAMP), in apical SNARE com-
plex formation (8). In these studies, the NEM treatment of
CaCo-2 cells increased the recovery of cellubrevin and
SNAP-23 associated with syntaxin 3; these authors reach the
conclusion that cellubrevin- and TI-VAMP-containing vesicles
dock at the apical plasma membrane through the NEM-de-
pendent formation of SNARE complexes, which include
SNAP23 and syntaxin 3.
The role of syntaxins in transcytosis was examined in MDCK
cells (54); transcytosis to the apical surface has been shown to
be dependent, at least in part, on NSF and a substrate that is
cleaved by botulinum E toxin, most likely a homologue of
SNAP-25. Therefore ,apical transcytosis may depend on a syn-
taxin (55). However, considering the published localization of
FIG. 6. Immunofluorescence stud-
ies of fluid phase and receptor-medi-
ated endocytosis in rat liver. Frozen
liver sections were used to study the or-
ganization and behavior of cellubrevin af-
ter the internalization of fluid phase
marker, dextran-FITC (Mr 70,000) (b) or
LDL (d), as a ligand that enters via recep-
tor-mediated endocytosis. In a, the pat-
tern of cellubrevin is shown after the in-
ternalization of dextran-FITC for 20 min;
c shows the same but after the internal-
ization of LDL (LDL was detected using a
rabbit anti-human apoB100 antibody). In
all panels, arrows point subapical and ar-
rowheads subsinusoidal labeled struc-
tures. n, nucleus; bar is 10 mm.
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the plasma membrane syntaxins in MDCK cells (7) and the
finding that synaptobrevin/VAMP-2 binds in vitro to the baso-
lateral syntaxin 4 but not to the apical syntaxins 2 or 3 (56, 57),
it seems only natural that apical membrane fusion should not
involve synaptobrevin/VAMP-2 and therefore is toxin-insensi-
tive (54).
In this study, for the first time, we show that in hepatocytes,
cellubrevin is almost restricted to tubulovesicular endocytic
structures in the subsinusoidal region. In isolated endosomes
from rat liver, it was enriched in the early/sorting and in the
“recycling” endosomes (58). The finding that cellubrevin was
subsequently enriched in a subpopulation of early endosomes
together with pIgA suggests that it may be committed to the
transport, from these early endosomes, into the transcytotic
pathway. This was supported in those experiments in which
the transcytotic pathway was overloaded with IgA; first, it
causes the formation of cellubrevin structures with a higher
density than those from the control, and, second, the reciprocal
coimmunoprecipitation of cellubrevin and pIgR from RRC sug-
gest that cellubrevin and pIgR are in the same vesicle. Thus,
cellubrevin becomes the third molecule with specific physical
association with the pIgR (calmodulin was the first (Ref. 33),
and p62yes the second (Ref. 26)).
Morphological approaches and the subcellular dissection of
early endocytic compartment of rat liver revealed: (i) that cel-
lubrevin may be a marker for the subsinusoidal endosomes and
(ii) the fact that cellubrevin-containing structures in the hep-
atocyte are transported together with pIgR-IgA from these
early/sorting endosomes (subsinusoidal domain), along the
transcytotic pathway, to the subapical endocytic compartment
is consistent with the recent view of the involvement of
SNAREs in transcytosis (59).
Finally, the presence of Raf-1 in the same endocytic subcom-
partment as cellubrevin suggests the functional complexity of
the subsinusoidal endocytic compartment of the hepatocyte.
Work in progress is focused on the molecular characterization
of the cellubrevin-pIgR interaction and to further understand
the involvement of cellubrevin in the transcytotic route.
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